$11M sweet spot round size
Most of their 45 investments are in rounds between $5.6M and $20M
2007
CatalYm GmbH raised $51M on November 22, 2022
Investors: Brandon Capital Partners, coparion, JEITO, BGV (BioGeneration Ventures), Forbion, Bayern Kapital GmbH and Vesalius Biocapital
Memo Therapeutics AG raised $25M on February 16, 2022
Investors: Zürcher Kantonalbank, Fresenius Medical Care, Adjuvant Capital and Vesalius Biocapital
Rejuvenate Biomed raised $18M on October 12, 2021
Investors: Rejuveron Life Sciences AG and Vesalius Biocapital
Undisclosed raised $130M on September 16, 2021
Investors: Partner Fund Management, ProAssurance, Optum Ventures, IPF Partners, Intel Capital, surgical.ai, Relyens, Lauxera Capital Partners and Vesalius Biocapital
Topas Therapeutics GmbH raised $21M on July 29, 2021
Investors: Gimv, Evotec, EMBL Ventures, Epidarex Capital, BioMedPartners and Vesalius Biocapital
Rejuvenate Biomed raised $3.8M on March 2, 2021
Investors: Vesalius Biocapital
Sword Health raised $25M on January 29, 2021
Investors: Founders Fund, BIO VITA srl, Leerink Transformation Partners, Faber Ventures, Khosla Ventures and Vesalius Biocapital
CatalYm GmbH raised $59M on November 19, 2020
Investors: coparion, BGV (BioGeneration Ventures), Forbion, StMWi and Vesalius Biocapital
Topas Therapeutics GmbH raised $26M on October 19, 2020
Investors: Gimv, BioMedPartners, Epidarex Capital and Vesalius Biocapital
Sword Health raised $9M on February 27, 2020
Investors: Founders Fund, BIO VITA srl, Faber Ventures, Khosla Ventures and Vesalius Biocapital